Literature DB >> 10893916

Incidence, clinical spectrum, and outcome of intrauterine infections in neonates.

A K Deorari1, S Broor, R S Maitreyi, D Agarwal, H Kumar, V K Paul, M Singh.   

Abstract

A prospective study was undertaken on the incidence of intrauterine infections by screening 1302 cord blood samples for total IgM by radial immunodiffusion. Specific IgM against cytomegalovirus (CMV), rubella and Toxoplasma were estimated in cord blood samples found to contain total IgM > 20 mg/dl. All these neonates were examined at birth and at discharge. Cord blood samples with total IgM > 20 mg/dl were further screened for specific IgM against rubella, CMV and Toxoplasma. Neonates found to have positive specific IgM were followed-up for hearing, opthalmological and developmental assessment. Raised cord blood (IgM > 20 mg/dl) was found in 270/1302 (20.6 per cent). Mean birth weight was comparable in babies with raised (> 20 mg/dl) or low (< 20 mg/dl) cord blood total IgM. Incidence of prematurity and low birth weight were not statistically different in babies with raised cord blood IgM when compared to those with low cord blood IgM levels. Similarly, incidence of intrauterine growth retardation (IUGR) idiopathic was similar in two groups. Specific IgM for rubella was found to be positive in eight (0.6 per cent). Of these, three had symptomatic rubella infection. Two mothers of these symptomatic babies had exanthematous viral illness during first trimester. Specific IgM for CMV was found to be positive in 23 (1.8 per cent) while two infants had symptomatic CMV disease. None of the babies was found to have specific IgM against Toxoplasma. One baby with symptomatic CMV disease and one with rubella died. Another baby with symptomatic CMV disease developed neonatal hepatitis which improved on follow-up but the infant went on to develop sensorineural deafness. All other asymptomatic babies with specific IgM positive against rubella and CMV were found to have normal vision, hearing and development on follow-up.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893916     DOI: 10.1093/tropej/46.3.155

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  10 in total

1.  An infant with congenital rubella syndrome in developing India.

Authors:  Ajit Singh; Sharon Narula; Hashir Kareem; Tom Devasia
Journal:  BMJ Case Rep       Date:  2017-11-28

Review 2.  Umbilical Cord Blood-Derived Exosomes in Maternal-Fetal Disease: a Review.

Authors:  Jingyi Liu; Wei Sun; Caixia Liu; Quan Na
Journal:  Reprod Sci       Date:  2022-02-14       Impact factor: 3.060

3.  Malondialdehyde, glutathione, and nitric oxide levels in Toxoplasma gondii seropositive patients.

Authors:  Ulku Karaman; Tuncay Celik; Tugba Raika Kiran; Cemil Colak; Nilgun Ulfet Daldal
Journal:  Korean J Parasitol       Date:  2008-12-20       Impact factor: 1.341

4.  Hospital-based surveillance of congenital rubella syndrome in Indonesia.

Authors:  Elisabeth Siti Herini; Agung Triono; Asal Wahyuni Erlin Mulyadi; Niprida Mardin; Yati Soenarto; Susan E Reef
Journal:  Eur J Pediatr       Date:  2017-01-13       Impact factor: 3.860

Review 5.  Congenital and perinatal infections: throwing new light with an old TORCH.

Authors:  Anita Shet
Journal:  Indian J Pediatr       Date:  2010-10-16       Impact factor: 5.319

6.  Prematurity and Low Birth Weight did not Correlate with Anti-Toxoplasma gondii Maternal Serum Profiles--a Brazilian Report.

Authors:  Mariana Machado Lemos Fochi; Sabrina Baring; Lígia Cosentino Junqueira Franco Spegiorin; Denise Cristina Mós Vaz-Oliani; Eloisa Aparecida Galão; Antonio Hélio Oliani; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

7.  Identification of congenital rubella syndrome in Sudan.

Authors:  Omer Adam; Ahmed K M Ali; Judith M Hübschen; Claude P Muller
Journal:  BMC Infect Dis       Date:  2014-06-04       Impact factor: 3.090

8.  Identifying Early Diagnostic Biomarkers Associated with Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Inn-Chi Lee; Swee-Hee Wong; Xing-An Wang; Chin-Sheng Yu
Journal:  Diagnostics (Basel)       Date:  2021-05-18

9.  Early Blood Glucose Level Post-Admission Correlates with the Outcomes and Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Inn-Chi Lee; Jiann-Jou Yang; Ying-Ming Liou
Journal:  Antioxidants (Basel)       Date:  2021-12-24

10.  Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis.

Authors:  Esther Ndungo; Liana R Andronescu; Andrea G Buchwald; Jose M Lemme-Dumit; Patricia Mawindo; Neeraj Kapoor; Jeff Fairman; Miriam K Laufer; Marcela F Pasetti
Journal:  Front Immunol       Date:  2021-10-15       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.